Simplex Trading’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
Simplex Trading's HCAT Position: Q2 2026 in Review
Simplex Trading reduced its Health Catalyst (HCAT) stake by 31% in Q2 2026, selling an estimated $6.09K and leaving 9,401 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7168.
Simplex Trading first reported a position in HCAT in Q4 2019 and has held it in 18 quarters since. The position peaked at $244K in Q3 2020. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Simplex Trading held 9,401 shares of Health Catalyst worth $18.7K as of Q2 2026.
- Simplex Trading sold 4,220 Health Catalyst shares in Q2 2026, an estimated $6.09K.
- Health Catalyst made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7168 holding.
- Simplex Trading first reported a position in Health Catalyst in Q4 2019 and has held it in 18 quarters since.
- Simplex Trading's Health Catalyst position peaked at $244K in Q3 2020.
- 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.